Business/EarningsArticle

Verrica Pharmaceuticals at H.C. Wainwright conference: growth and pipeline

Verrica Pharmaceuticals will address growth and pipeline developments during its appearance at the H.C. Wainwright conference.

PA

Priya Anand · Equities & Earnings Desk · 14 Sept 2026 · 19:27 · 1 min read

Share

Verrica Pharmaceuticals at H.C. Wainwright conference: growth and pipeline

Verrica Pharmaceuticals is scheduled to speak at the H.C. Wainwright conference, where it will discuss growth and pipeline.

Additional details on the company's business developments were not immediately available.

Earnings

This article was produced with AI assistance and edited by a Finance Review Daily journalist.

Share this story

PA

Written by

Priya Anand

Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

Market Snapshot

Delayed

EUR/USD1.1541▼ 0.50%GBP/USD1.3482▼ 0.33%USD/CHF0.8186▲ 0.26%BTC/USD78,185.64▲ 1.75%ETH/USD2,518.57▲ 1.67%XAU/USD4,287.04▼ 1.41%

Royalty Pharma says growth expanding beyond royalties at Morgan Stanley conference

Priya Anand · 16 min ago

Earnings

Verrica Pharmaceuticals at H.C. Wainwright conference: growth and pipeline

Market Snapshot

Related Reading

Royalty Pharma says growth expanding beyond royalties at Morgan Stanley conference

Zoetis pipeline offsets near-term pricing pressure, CFO says

ALX Oncology Projects Cash Runway Through 2028, Outlines Two Drug Catalysts

Verastem Oncology to Present Dual-Track RAS Strategy at H.C. Wainwright

Schrödinger lifts software guidance as hosted revenue hits 47% of total